Phaseline

Companies › Lantheus Medical Imaging

Lantheus Medical Imaging: clinical trials, targets and expected readouts

4 active drug programs in 4 registered trials: 2 Phase 1, 1 Phase 4, 1 Phase 2; Oncology; next expected readout Aug 2027.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Piflufolastat F 18
Prostate-specific membrane antigen (PSMA)-targeting PET imaging agent
PSMAPhase 4Prostate Cancer–
[68Ga]-LNTH-2401
PSMA-targeting positron emission tomography (PET) imaging agent
PSMA1Phase 2Prostate CancerSep 2029
LNTH-2403
177Lu-labeled targeted osteosarcoma therapy (mechanism not specified in registry)
–Phase 1Relapsed / Refractory OsteosarcomaAug 2027
64Cu-LNTH-1363S
FAP inhibitor radiolabeled with Copper-64 (64Cu) for PET/CT imaging
FAPPhase 1Metastatic Sarcoma–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT0629891664Cu-LNTH-1363SPhase 1Metastatic SarcomaOncologyNov 2025
NCT06074510Piflufolastat F 18Phase 4Prostate CancerOncologySep 2026
NCT07357519LNTH-2403Phase 1Relapsed / Refractory OsteosarcomaOncologyAug 2027
NCT07831824[68Ga]-LNTH-2401Phase 2Prostate CancerOncologySep 2029

From the company's SEC filings

Private offerings reported to the SEC (Form D)

Targets

PSMA (1) PSMA1 (1) FAP (1)

Companies with the same targets

Clarity Pharmaceuticals C Ray Therapeutics Beijing Biotech Chengdu New Radiomedicine Technology Avacta Life Sciences Blue Earth Diagnostics Nova Therapeutics Eli Lilly Fusion Pharmaceuticals Sinotau Pharmaceutical Group

Companies built like this

Blue Earth Diagnostics Chengdu New Radiomedicine Technology Clarity Pharmaceuticals Norroy Bioscience SOFIE

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.